K. L. Dehne, G. Dallabetta, D. Wilson, G. P. Garnett, M. Laga et al., HIV prevention 2020: a framework for delivery and a call for action, Lancet HIV, vol.3, issue.7, pp.323-355, 2016.

E. W. Fiebig, D. J. Wright, B. D. Rawal, P. E. Garrett, R. T. Schumacher et al., Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection, Aids, vol.17, issue.13, pp.1871-79, 2003.

, DHHS. Panel on antiretroviral guidelines for adults and adolescents

C. D. Pilcher, G. Joaki, I. F. Hoffman, F. E. Martinson, C. Mapanje et al., Amplified transmission of HIV-1: comparison of HIV-1 concentrations in semen and blood during acute and chronic infection, Aids, vol.21, issue.13, pp.1723-1753, 2007.

C. D. Pilcher, D. C. Shugars, S. A. Fiscus, W. C. Miller, P. Menezes et al., HIV in body fluids during primary HIV infection: implications for pathogenesis, treatment and public health, Aids, vol.15, issue.7, pp.837-882, 2001.

C. D. Pilcher, H. C. Tien, J. J. Eron, P. L. Vernazza, S. Y. Leu et al., Brief but efficient: acute HIV infection and the sexual transmission of HIV, J Infect Dis, vol.189, issue.10, pp.1785-92, 2004.

C. S. Morrison, K. Demers, C. Kwok, S. Bulime, A. Rinaldi et al., Plasma and cervical viral loads among Ugandan and Zimbabwean women during acute and early HIV-1 infection, Aids, vol.24, issue.4, pp.573-82, 2010.

K. A. Powers, A. C. Ghani, W. C. Miller, I. F. Hoffman, A. E. Pettifor et al., The role of acute and early HIV infection in the spread of HIV and implications for transmission prevention strategies in Lilongwe, Malawi: a modelling study, Lancet, vol.378, issue.9787, pp.256-68, 2011.

M. Battegay, J. D. Lundgren, and L. Ryom, European AIDS clinical society Brussels, 2017.

, Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents, 2015.

D. Gokengin, A. M. Geretti, J. Begovac, A. Palfreeman, M. Stevanovic et al., European guideline on HIV testing, Int J STD AIDS, vol.25, issue.10, pp.695-704, 2014.

. Ias-usa, Antiretroviral treatment of adult HIV infection: 2014 recommendations of the international antiviral society-USA panel, 2013.

, Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach, 2016.

, Consolidated guidelines on HIV testing services, 2015.

V. A. Fonner, S. L. Dalglish, C. E. Kennedy, R. Baggaley, K. R. O'reilly et al., Effectiveness and safety of oral HIV preexposure prophylaxis for all populations, Aids, vol.30, issue.12, pp.1973-83, 2016.

J. Z. Li, B. Etemad, H. Ahmed, E. Aga, R. J. Bosch et al., The size of the expressed HIV reservoir predicts timing of viral rebound after treatment interruption, Aids, vol.30, issue.3, pp.343-53, 2016.

J. Ananworanich, K. Dube, and N. Chomont, How does the timing of antiretroviral therapy initiation in acute infection affect HIV reservoirs?, Curr Opin HIV AIDS, vol.10, issue.1, pp.18-28, 2015.

N. M. Archin, N. K. Vaidya, J. D. Kuruc, A. L. Liberty, A. Wiegand et al., Immediate antiviral therapy appears to restrict resting CD4+ cell HIV-1 infection without accelerating the decay of latent infection, PNAS, vol.109, issue.24, pp.9523-9551, 2012.

S. J. Krebs and J. Ananworanich, Immune activation during acute HIV infection and the impact of early antiretroviral therapy, Curr Opin HIV AIDS, vol.11, issue.2, pp.163-72, 2016.

M. Fisher, D. Pao, A. E. Brown, D. Sudarshi, O. N. Gill et al., Determinants of HIV-1 transmission in men who have sex with men: a combined clinical, epidemiological and phylogenetic approach, Aids, vol.24, issue.11, pp.1739-1786, 2010.

M. Hoenigl, J. Graff-zivin, and S. J. Little, Costs per diagnosis of acute HIV infection in community-based screening strategies: a comparative analysis of four screening algorithms, Clin Infect Dis, vol.62, issue.4, pp.501-512, 2016.

J. D. Kuruc, A. B. Cope, L. A. Sampson, C. L. Gay, R. M. Ashby et al., Ten years of screening and testing for acute HIV infection in North Carolina, J Acquir Immune Defic Syndr, vol.71, issue.1, pp.111-130, 2016.

P. J. White, J. Fox, J. Weber, S. Fidler, and H. Ward, How many HIV infections may be averted by targeting primary infection in men who have sex with men? Quantification of changes in transmission-risk behavior, using an individualbased model, J Infect Dis, vol.210, issue.2, pp.594-603, 2014.

P. Phanuphak and Y. R. Lo, Implementing early diagnosis and treatment: programmatic considerations, Curr Opin HIV AIDS, vol.10, issue.1, pp.69-75, 2015.

A. B. Suthar, R. M. Granich, M. Kato, S. Nsanzimana, J. S. Montaner et al., Programmatic implications of acute and early HIV infection, J Infect Dis, vol.212, issue.9, pp.1351-60, 2015.

H. Arksey, O. Malley, and L. , Scoping studies: towards a methodological framework, Int J Soc Res Methodol, vol.8, issue.1, pp.19-32, 2005.

N. Mays, E. Roberts, and J. Popay, Studying the organisation and delivery of health services: research methods, pp.188-220, 2001.

J. M. Carlson, M. Schaefer, D. C. Monaco, R. Batorsky, D. T. Claiborne et al., HIV transmission. Selection bias at the heterosexual HIV-1 transmission bottleneck, Science, vol.345, issue.6193, p.1254031, 2014.

T. C. Quinn, R. Brookmeyer, R. Kline, M. Shepherd, R. Paranjape et al., Feasibility of pooling sera for HIV-1 viral RNA to diagnose acute primary HIV-1 infection and estimate HIV incidence, Aids, vol.14, issue.17, pp.2751-57, 2000.

M. L. Robb, L. A. Eller, H. Kibuuka, K. Rono, L. Maganga et al., Prospective study of acute HIV-1 infection in adults in East Africa and Thailand, N Engl J Med, vol.374, pp.2120-2150, 2016.

M. J. Wawer, N. K. Sewankambo, D. Serwadda, T. C. Quinn, L. A. Paxton et al., Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial. Rakai Project Study Group, Lancet, vol.353, issue.9152, pp.525-560, 1999.

S. E. Rutstein, Journal of the International AIDS Society, vol.20, 2017.

M. J. Wawer, R. H. Gray, N. K. Sewankambo, D. Serwadda, X. Li et al., Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, J Infect Dis, vol.191, issue.9, pp.1403-1412, 2005.

T. D. Hollingsworth, R. M. Anderson, and C. Fraser, HIV-1 transmission, by stage of infection, J Infect Dis, vol.198, issue.5, pp.687-93, 2008.

S. E. Bellan, J. Dushoff, A. P. Galvani, and L. A. Meyers, Reassessment of HIV-1 acute phase infectivity: accounting for heterogeneity and study design with simulated cohorts, Plos Med, vol.12, issue.3, p.1001801, 2015.

D. Bezemer, A. Van-sighem, V. V. Lukashov, L. Van-der-hoek, N. Back et al., Transmission networks of HIV-1 among men having sex with men in the Netherlands, Aids, vol.24, issue.2, pp.271-82, 2010.

S. English, A. Katzourakis, D. Bonsall, P. Flanagan, A. Duda et al., Phylogenetic analysis consistent with a clinical history of sexual transmission of HIV-1 from a single donor reveals transmission of highly distinct variants, Retrovirology, vol.8, p.54, 2011.

T. D. Hollingsworth, C. D. Pilcher, F. M. Hecht, S. G. Deeks, and C. Fraser, High Transmissibility During early HIV infection among men who have sex with men, J Infect Dis, vol.211, issue.11, pp.1757-60, 2015.

R. D. Kouyos, V. Wyl, V. Yerly, S. Boni, J. Taffe et al., Molecular epidemiology reveals long-term changes in HIV type 1 subtype B transmission in Switzerland, J Infect Dis, vol.201, issue.10, pp.1488-97, 2010.

D. Pao, M. Fisher, S. Hue, G. Dean, G. Murphy et al., Transmission of HIV-1 during primary infection: relationship to sexual risk and sexually transmitted infections, Aids, vol.19, issue.1, pp.85-90, 2005.

B. G. Brenner, M. Roger, D. Stephens, D. Moisi, I. Hardy et al., Transmission clustering drives the onward spread of the HIV epidemic among men who have sex with men in Quebec, J Infect Dis, vol.204, issue.7, pp.1115-1134, 2011.

A. E. Brown, R. J. Gifford, J. P. Clewley, C. Kucherer, B. Masquelier et al., Phylogenetic reconstruction of transmission events from individuals with acute HIV infection: toward more-rigorous epidemiological definitions, J Infect Dis, vol.199, issue.3, pp.427-458, 2009.

D. Chibo, M. Kaye, and C. Birch, HIV transmissions during seroconversion contribute significantly to new infections in men who have sex with men in Australia, AIDS Res Hum Retroviruses, vol.28, issue.5, pp.460-64, 2012.

P. Frange, L. Meyer, C. Deveau, L. Tran, C. Goujard et al., Recent HIV-1 infection contributes to the viral diffusion over the French territory with a recent increasing frequency, Plos One, vol.7, issue.2, p.31695, 2012.

B. G. Brenner, M. Roger, J. P. Routy, D. Moisi, M. Ntemgwa et al., High rates of forward transmission events after acute/early HIV-1 infection, J Infect Dis, vol.195, issue.7, pp.951-59, 2007.

O. Ratmann, A. Van-sighem, D. Bezemer, A. Gavryushkina, S. Jurriaans et al., Sources of HIV infection among men having sex with men and implications for prevention, Sci Transl Med, vol.8, issue.320, pp.320-322, 2016.

A. M. Dennis, J. T. Herbeck, A. L. Brown, P. Kellam, D. Oliveira et al., Phylogenetic studies of transmission dynamics in generalized HIV epidemics: an essential tool where the burden is greatest?, J Acquir Immune Defic Syndr, vol.67, issue.2, pp.181-95, 2014.

W. C. Miller, N. E. Rosenberg, S. E. Rutstein, and K. A. Powers, Role of acute and early HIV infection in the sexual transmission of HIV, Curr Opin HIV AIDS, vol.5, issue.4, pp.277-82, 2010.

S. D. Pinkerton, How many sexually-acquired HIV infections in the USA are due to acute-phase HIV transmission?, Aids, vol.21, issue.12, pp.1625-1654, 2007.

V. S. Prabhu, A. B. Hutchinson, P. G. Farnham, and S. L. Sansom, Sexually acquired HIV infections in the USA due to acute-phase HIV transmission: an update, Aids, vol.23, issue.13, pp.1792-94, 2009.

M. Xiridou, R. Geskus, D. Wit, J. Coutinho, R. Kretzschmar et al., Primary HIV infection as source of HIV transmission within steady and casual partnerships among homosexual men, Aids, vol.18, issue.9, pp.1311-1331, 2004.

M. S. Cohen, G. M. Shaw, A. J. Mcmichael, and B. F. Haynes, Acute HIV-1 infection, N Engl J Med, vol.364, issue.20, pp.1943-54, 2011.

E. M. Volz, E. Ionides, E. O. Romero-severson, M. G. Brandt, E. Mokotoff et al., HIV-1 transmission during early infection in men who have sex with men: a phylodynamic analysis, Plos Med, vol.10, issue.12, p.1001568, 2013.

L. J. Abu-raddad and I. M. Longini, No HIV stage is dominant in driving the HIV epidemic in sub-Saharan Africa, Aids, vol.22, issue.9, pp.1055-61, 2008.

B. G. Williams, R. Granich, and C. Dye, Role of acute infection in HIV transmission, Lancet, vol.378, issue.9807, 1913.

. Popart, . Clinicaltrials, and . Gov, , 2016.

, SEARCH. Clinicaltrials.gov, 2016.

A. Kfutwah, V. Lemee, H. V. Ngono, D. Oliveira, F. Njouom et al., Field evaluation of the Abbott ARCHITECT HIV Ag/Ab Combo immunoassay, J Clin Virol, vol.58, issue.1, pp.70-75, 2013.

J. S. Haukoos, M. S. Lyons, D. A. White, Y. H. Hsieh, and R. E. Rothman, Acute HIV infection and implications of fourth-generation HIV screening in emergency departments, Ann Emerg Med, vol.64, issue.5, pp.547-51, 2014.

P. Patel, B. Bennett, T. Sullivan, M. M. Parker, J. D. Heffelfinger et al., Rapid HIV screening: missed opportunities for HIV diagnosis and prevention, J Clin Virol, vol.54, issue.1, pp.42-47, 2012.

E. Piwowar-manning, J. M. Fogel, P. Richardson, S. Wolf, W. Clarke et al., Performance of the fourth-generation Bio-Rad GS HIV Combo Ag/ Ab enzyme immunoassay for diagnosis of HIV infection in Southern Africa, J Clin Virol, vol.62, pp.75-79, 2015.

K. I. Geren, F. Lovecchio, J. Knight, R. Fromm, E. Moore et al., Identification of acute HIV infection using fourth-generation testing in an opt-out emergency department screening program, Ann Emerg Med, vol.64, issue.5, pp.537-583, 2014.

T. D. Ly, A. Ebel, V. Faucher, V. Fihman, and S. Laperche, Could the new HIV combined p24 antigen and antibody assays replace p24 antigen specific assays?, J Virol Methods, vol.143, issue.1, pp.86-94, 2007.

P. J. Peters, E. Westheimer, S. Cohen, L. B. Hightow-weidman, N. Moss et al., Screening yield of HIV antigen/antibody combination and pooled HIV RNA testing for acute HIV infection in a high-prevalence population, Jama, vol.315, issue.7, pp.682-90, 2016.

S. Jurriaans, N. K. Back, and K. C. Wolthers, Ten years of HIV testing with fourth generation assays: the Amsterdam experience, J Clin Virol, vol.52, issue.1, pp.67-76, 2011.

, Laboratory testing for the diagnosis of HIV infection: updated recommendations, Centers for Disease Control and Prevention (CDC)

D. Souza, M. Phanuphak, N. Pinyakorn, S. Trichavaroj, R. Pattanachaiwit et al., Impact of nucleic acid testing relative to antigen/antibody combination immunoassay on the detection of acute HIV infection, Aids, vol.29, pp.793-800, 2015.

M. Krajden, D. Cook, A. Mak, K. Chu, N. Chahil et al., Pooled nucleic acid testing increases the diagnostic yield of acute HIV infections in a high-risk population compared to 3rd and 4th generation HIV enzyme immunoassays, J Clin Virol, vol.61, issue.1, pp.132-169, 2014.

D. Souza, M. S. Pinyakorn, S. Akapirat, S. Pattanachaiwit, S. Fletcher et al., Initiation of antiretroviral therapy during acute HIV-1 infection leads to a high rate of nonreactive HIV serology, Clin Infect Dis, vol.63, pp.555-61, 2016.

. Rv254/search010, . Clinicaltrials, and . Gov, , 2016.

E. M. Ramos, S. Harb, J. Dragavon, P. Swenson, J. D. Stekler et al., Performance of an alternative HIV diagnostic algorithm using the ARCHITECT HIV Ag/Ab Combo assay and potential utility of sample-tocutoff ratio to discriminate primary from established infection, J Clin Virol, vol.58, issue.1, pp.38-43, 2013.

M. C. Thigpen, P. M. Kebaabetswe, L. A. Paxton, D. K. Smith, C. E. Rose et al., Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana, N Engl J Med, vol.367, issue.5, pp.423-457, 2012.

J. M. Baeten, D. Donnell, P. Ndase, N. R. Mugo, J. D. Campbell et al., Antiretroviral prophylaxis for HIV prevention in heterosexual men and women, N Engl J Med, vol.367, issue.5, pp.399-410, 2012.

R. M. Grant, J. R. Lama, P. L. Anderson, V. Mcmahan, A. Y. Liu et al., Preexposure chemoprophylaxis for HIV prevention in men who have sex with men, N Engl J Med, vol.363, issue.27, pp.2587-99, 2010.

L. Van-damme, A. Corneli, K. Ahmed, K. Agot, J. Lombaard et al., Preexposure prophylaxis for HIV infection among African women, N Engl J Med, vol.367, issue.5, pp.411-433, 2012.

I. V. Bassett, S. Chetty, J. Giddy, S. Reddy, K. Bishop et al., Screening for acute HIV infection in South Africa: finding acute and chronic disease, HIV Med, vol.12, issue.1, pp.46-53, 2011.

L. M. Bebell, C. D. Pilcher, G. Dorsey, D. Havlir, M. R. Kamya et al., Acute HIV-1 infection is highly prevalent in Ugandan adults with suspected malaria, Aids, vol.24, issue.12, pp.1945-52, 2010.

S. E. Rutstein, Journal of the International AIDS Society, vol.20, 2017.

S. A. Fiscus, C. D. Pilcher, W. C. Miller, K. A. Powers, I. F. Hoffman et al., Rapid, real-time detection of acute HIV infection in patients in Africa, J Infect Dis, vol.195, issue.3, pp.416-440, 2007.

N. Gous, L. Scott, O. Perovic, F. Venter, and W. Stevens, Should South Africa be performing nucleic acid testing on HIV enzyme-linked immunosorbent assaynegative samples?, J Clin Microbiol, vol.48, issue.9, pp.3407-3416, 2010.

J. Li, H. Zhang, Z. Shen, Y. Zhou, N. Fang et al., Screening for acute HIV infections and estimating HIV incidence among female sex workers from low-grade venues in Guangxi, China, PLoS One, vol.9, issue.6, p.99522, 2014.

K. Mlisana, M. Sobieszczyk, L. Werner, A. Feinstein, F. Van-loggerenberg et al., Challenges of diagnosing acute HIV-1 subtype C infection in African women: performance of a clinical algorithm and the need for pointof-care nucleic-acid based testing, PLoS One, vol.8, issue.4, p.62928, 2013.

C. D. Pilcher, M. A. Price, I. F. Hoffman, S. Galvin, F. E. Martinson et al., Frequent detection of acute primary HIV infection in men in Malawi, Aids, vol.18, issue.3, pp.517-541, 2004.

S. E. Rutstein, A. E. Pettifor, S. Phiri, G. Kamanga, I. F. Hoffman et al., Incorporating acute HIV screening into routine HIV testing at sexually transmitted infection clinics, and HIV testing and counseling centers in Lilongwe, Malawi, J Acquir Immune Defic Syndr, vol.71, issue.3, pp.272-80, 2016.

C. Serna-bolea, J. Munoz, J. M. Almeida, A. Nhacolo, E. Letang et al., High prevalence of symptomatic acute HIV infection in an outpatient ward in southern Mozambique: identification and follow-up, Aids, vol.24, issue.4, pp.603-611, 2010.

L. Cragin, F. Pan, S. Peng, J. M. Zenilman, J. Green et al., Costeffectiveness of a fourth-generation combination immunoassay for human immunodeficiency virus (HIV) antibody and p24 antigen for the detection of HIV infections in the USA, HIV Clin Trials, vol.13, issue.1, pp.11-22, 2012.

J. L. Juusola, M. L. Brandeau, E. F. Long, D. K. Owens, and E. Bendavid, The costeffectiveness of symptom-based testing and routine screening for acute HIV infection in men who have sex with men in the USA, Aids, vol.25, issue.14, pp.1779-87, 2011.

M. Y. Karris, C. M. Anderson, S. R. Morris, D. M. Smith, and S. J. Little, Cost savings associated with testing of antibodies, antigens, and nucleic acids for diagnosis of acute HIV infection, J Clin Microbiol, vol.50, issue.6, pp.1874-78, 2012.

M. Hoenigl, A. Chaillon, S. R. Mehta, D. M. Smith, J. Graff-zivin et al., Screening for acute HIV infection in community-based settings: cost-effectiveness and impact on transmissions, J Infect, vol.73, pp.476-84, 2016.

C. D. Pilcher, S. A. Fiscus, T. Q. Nguyen, E. Foust, L. Wolf et al., Detection of acute infections during HIV testing in North Carolina, N Engl J Med, vol.352, issue.18, pp.1873-83, 2005.

J. D. Klausner, R. M. Grant, and C. K. Kent, Detection of acute HIV infections, N Engl J Med, vol.353, issue.6, pp.631-664, 2005.

A. B. Hutchinson, P. Patel, S. L. Sansom, P. G. Farnham, T. J. Sullivan et al., Cost-effectiveness of pooled nucleic acid amplification testing for acute HIV infection after third-generation HIV antibody screening and rapid testing in the USA: a comparison of three public health settings, Plos Med, vol.7, issue.9, p.1000342, 2010.

B. Emerson and K. Plough, Detection of acute HIV-1 infections utilizing NAAT technology in, J Clin Virol, vol.58, issue.1, pp.48-53, 2013.

, Geneva: WHO, Prequalification of In Vitro Diagnostics: PUBLIC REPORT (Alere? HIV Combo), 2016.

M. Smallwood, R. Vijh, B. Nauche, B. Lebouche, L. Joseph et al., Evaluation of a rapid point of care test for detecting acute and established HIV infection, and examining the role of study quality on diagnostic accuracy: a bayesian meta-analysis, Plos One, vol.11, issue.2, p.149592, 2016.

D. P. Conway, M. Holt, A. Mcnulty, D. L. Couldwell, D. E. Smith et al., Multi-centre evaluation of the determine HIV combo assay when used for point of care testing in a high risk clinic-based population, Plos One, vol.9, issue.4, p.94062, 2014.

Y. T. Duong, Y. Mavengere, H. Patel, C. Moore, J. Manjengwa et al., Poor performance of the determine HIV-1/2 Ag/Ab combo fourthgeneration rapid test for detection of acute infections in a national household survey in Swaziland, J Clin Microbiol, vol.52, issue.10, pp.3743-3791, 2014.

N. E. Rosenberg, G. Kamanga, S. Phiri, D. Nsona, A. Pettifor et al., Detection of acute HIV infection: a field evaluation of the determine(R)

, Ag/Ab combo test, J Infect Dis, vol.205, issue.4, pp.528-562, 2012.

C. B. Jones, K. Kuldanek, D. Muir, K. Phekoo, A. Black et al., Clinical evaluation of the Determine HIV-1/2 Ag/Ab Combo test, J Infect Dis, vol.206, issue.12, pp.1947-1996, 2012.

J. M. Lewis, P. Macpherson, E. R. Adams, E. Ochodo, A. Sands et al., Field accuracy of fourth-generation rapid diagnostic tests for acute HIV-1: a systematic review, Aids, vol.29, issue.18, pp.2465-71, 2015.

N. Fitzgerald, M. Cross, O. Shea, S. Fox, and J. , Diagnosing acute HIV infection at point of care: a retrospective analysis of the sensitivity and specificity of a fourth-generation point-of-care test for detection of HIV core protein p24, Sex Transm Infect, vol.93, issue.2, pp.100-101, 2017.

S. M. Keating, R. Kassanjee, M. Lebedeva, S. N. Facente, J. C. Macarthur et al., Performance of the bio-rad geenius HIV1/2 supplemental assay in detecting 'recent' HIV infection and calculating population incidence, J Acquir Immune Defic Syndr, vol.73, pp.581-88, 2016.

I. V. Jani, B. Meggi, N. Mabunda, A. Vubil, N. E. Sitoe et al., Accurate early infant HIV diagnosis in primary health clinics using a point-ofcare nucleic acid test, J Acquir Immune Defic Syndr, vol.67, issue.1, pp.1-4, 2014.

, Prequalification of in vitro diagnostics: PUBLIC REPORT (Alere? q HIV-1/2 Detect), 2016.

A. V. Ritchie, I. Ushiro-lumb, D. Edemaga, H. A. Joshi, D. Ruiter et al., SAMBA HIV semiquantitative test, a new point-of-care viral-load-monitoring assay for resource-limited settings, J Clin Microbiol, vol.52, issue.9, pp.3377-83, 2014.

L. Scott, N. Gous, S. Carmona, and W. Stevens, Laboratory evaluation of the liat HIV quant (IQuum) whole blood and plasma HIV-1 viral load assays for point-of-care testing in South Africa, J Clin Microbiol, vol.53, pp.1616-1637, 2015.

N. J. Garrett, P. K. Drain, L. Werner, N. Samsunder, A. Karim et al., Diagnostic accuracy of the point-of-care xpert HIV-1 viral load assay in a South African HIV clinic, J Acquir Immune Defic Syndr, vol.72, issue.2, pp.45-53, 2016.

M. Michaeli, M. Wax, Y. Gozlan, A. Rakovsky, E. Mendelson et al., Evaluation of xpert HIV-1 qual assay for resolution of HIV-1 infection in samples with negative or indeterminate geenius HIV-1/2 results, J Clin Virol, vol.76, pp.1-3, 2016.

M. Hoenigl, N. Green, M. Camacho, S. Gianella, S. R. Mehta et al., Signs or symptoms of acute HIV infection in a cohort undergoing community-based screening, Emerg Infect Dis, vol.22, issue.3, pp.532-566, 2016.

E. J. Sanders, E. Wahome, M. Mwangome, A. N. Thiong'o, H. S. Okuku et al., Most adults seek urgent healthcare when acquiring HIV-1 and are frequently treated for malaria in coastal Kenya, Aids, vol.25, issue.9, pp.1219-1243, 2011.

D. Sudarshi, D. Pao, G. Murphy, J. Parry, G. Dean et al., Missed opportunities for diagnosing primary HIV infection, Sex Transm Infect, vol.84, issue.1, pp.14-16, 2008.

K. A. Powers and M. S. Cohen, Acute HIV-1 infection in sub-Saharan Africa: a common occurrence overlooked, Aids, vol.28, issue.9, pp.1365-67, 2014.

H. A. Prins, P. Mugo, E. Wahome, G. Mwashigadi, A. Thiong'o et al., Diagnosing acute and prevalent HIV-1 infection in young African adults seeking care for fever: a systematic review and audit of current practice, Int Health, vol.6, issue.2, pp.82-92, 2014.

E. J. Sanders, P. Mugo, H. A. Prins, E. Wahome, A. N. Thiong'o et al., Acute HIV-1 infection is as common as malaria in young febrile adults seeking care in coastal Kenya, Aids, vol.28, issue.9, pp.1357-63, 2014.

S. Lindback, A. C. Karlsson, J. Mittler, A. Blaxhult, M. Carlsson et al., Viral dynamics in primary HIV-1 infection. Karolinska Institutet Primary HIV Infection Study Group, Aids, vol.14, issue.15, pp.2283-91, 2000.

L. Lavreys, J. M. Baeten, J. Overbaugh, D. D. Panteleeff, B. H. Chohan et al., Virus load during primary human immunodeficiency virus (HIV) type 1 infection is related to the severity of acute HIV illness in Kenyan women, Clin Infect Dis, vol.35, issue.1, pp.77-81, 2002.

E. J. Sanders, O. Chirro, C. Oduor, J. Mangi, E. Wahome et al., Outcomes of AHI screening and immediate ART initiation in Coastal Kenya, 2017.

L. Lavreys, J. M. Baeten, V. Chohan, R. S. Mcclelland, W. M. Hassan et al., Higher set point plasma viral load and more-severe acute HIV type 1 (HIV-1) illness predict mortality among high-risk HIV-1-infected African women, Clin Infect Dis, vol.42, issue.9, pp.1333-1372, 2006.

E. J. Sanders, E. Wahome, K. A. Powers, L. Werner, G. Fegan et al., Targeted screening of at-risk adults for acute HIV-1 infection in sub-Saharan Africa, Aids, vol.29, issue.3, pp.221-251, 2015.

K. A. Powers, W. C. Miller, C. D. Pilcher, C. Mapanje, F. E. Martinson et al., Improved detection of acute HIV-1 infection in sub-Saharan Africa: development of a risk score algorithm, Aids, vol.21, issue.16, pp.2237-2279, 2007.

E. Wahome, G. Fegan, H. S. Okuku, P. Mugo, M. A. Price et al., Evaluation of an empiric risk screening score to identify acute and early HIV-1 infection among MSM in Coastal Kenya, Aids, vol.27, issue.13, pp.2163-66, 2013.

S. E. Rutstein, Journal of the International AIDS Society, vol.20, 2017.

M. L. Grijsen, R. Steingrover, F. W. Wit, S. Jurriaans, A. Verbon et al., No treatment versus 24 or 60 weeks of antiretroviral treatment during primary HIV infection: the randomized Primo-SHM trial, PLoS Med, vol.9, issue.3, p.1001196, 2012.

A. Saez-cirion, C. Bacchus, L. Hocqueloux, V. Avettand-fenoel, I. Girault et al., Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study, PLoS Pathog, vol.9, issue.3, p.1003211, 2013.
URL : https://hal.archives-ouvertes.fr/pasteur-01420534

S. Fidler, K. Porter, F. Ewings, J. Frater, G. Ramjee et al., Shortcourse antiretroviral therapy in primary HIV infection, N Engl J Med, vol.368, issue.3, pp.207-224, 2013.

A. J. Mcmichael, P. Borrow, G. D. Tomaras, N. Goonetilleke, and B. F. Haynes, The immune response during acute HIV-1 infection: clues for vaccine development, Nat Rev Immunol, vol.10, issue.1, pp.11-23, 2010.

M. J. Buzon, E. Martin-gayo, F. Pereyra, Z. Ouyang, H. Sun et al., Longterm antiretroviral treatment initiated at primary HIV-1 infection affects the size, composition, and decay kinetics of the reservoir of HIV-1-infected CD4 T cells, J Virol, vol.88, issue.17, pp.10056-65, 2014.

A. Cheret, C. Bacchus-souffan, V. Avettand-fenoel, A. Melard, G. Nembot et al., Combined ART started during acute HIV infection protects central memory CD4+ T cells and can induce remission, J Antimicrob Chemother, vol.70, issue.7, pp.2108-2128, 2015.
URL : https://hal.archives-ouvertes.fr/pasteur-01420415

M. C. Strain, S. J. Little, E. S. Daar, D. V. Havlir, H. F. Gunthard et al., Effect of treatment, during primary infection, on establishment and clearance of cellular reservoirs of HIV-1, J Infect Dis, vol.191, issue.9, pp.1410-1428, 2005.

J. Ananworanich, A. Schuetz, C. Vandergeeten, I. Sereti, D. Souza et al., Impact of multi-targeted antiretroviral treatment on gut T cell depletion and HIV reservoir seeding during acute HIV infection, PLoS One, vol.7, issue.3, p.33948, 2012.

M. Laanani, J. Ghosn, A. Essat, A. Melard, R. Seng et al., Impact of the timing of initiation of antiretroviral therapy during primary HIV-1 infection on the decay of cell-associated HIV-DNA, Clin Infect Dis, vol.60, issue.11, pp.1715-1736, 2015.

K. M. Bruner, A. J. Murray, R. A. Pollack, M. G. Soliman, S. B. Laskey et al., Defective proviruses rapidly accumulate during acute HIV-1 infection, Nat Med, vol.22, pp.1043-1092, 2016.

K. Allers, A. Puyskens, H. J. Epple, D. Schurmann, J. Hofmann et al., The effect of timing of antiretroviral therapy on CD4(+) T-cell reconstitution in the intestine of HIV-infected patients, Mucosal Immunol, vol.9, issue.1, pp.265-74, 2016.

M. A. Jenabian, M. El-far, K. Vyboh, I. Kema, C. T. Costiniuk et al., Immunosuppressive tryptophan catabolism and gut mucosal dysfunction following early HIV infection, J Infect Dis, vol.212, issue.3, pp.355-66, 2015.

J. Ananworanich, N. Chomont, L. A. Eller, E. Kroon, S. Tovanabutra et al., HIV DNA set point is rapidly established in acute HIV infection and dramatically reduced by early ART, EBioMedicine, vol.11, pp.68-72, 2016.

G. J. Besson, C. M. Lalama, R. J. Bosch, R. T. Gandhi, M. A. Bedison et al., HIV-1 DNA decay dynamics in blood during more than a decade of suppressive antiretroviral therapy, Clin Infect Dis, vol.59, issue.9, pp.1312-1333, 2014.

J. M. Murray, J. J. Zaunders, K. L. Mcbride, Y. Xu, M. Bailey et al., HIV DNA subspecies persist in both activated and resting memory CD4+ T cells during antiretroviral therapy, J Virol, vol.88, issue.6, pp.3516-3542, 2014.

M. K. Rothenberger, B. F. Keele, S. W. Wietgrefe, C. V. Fletcher, G. J. Beilman et al., Large number of rebounding/founder HIV variants emerge from multifocal infection in lymphatic tissues after treatment interruption, Proc Natl Acad Sci, vol.112, issue.10, pp.1126-1160, 2015.

V. Jain, W. Hartogensis, P. Bacchetti, P. W. Hunt, H. Hatano et al., Antiretroviral therapy initiated within 6 months of HIV infection is associated with lower T-cell activation and smaller HIV reservoir size, J Infect Dis, vol.208, issue.8, pp.1202-1213, 2013.

T. Le, E. J. Wright, D. M. Smith, W. He, G. Catano et al., Enhanced CD4+ T-cell recovery with earlier HIV-1 antiretroviral therapy, N Engl J Med, vol.368, issue.3, pp.218-248, 2013.

A. Schuetz, C. Deleage, I. Sereti, R. Rerknimitr, N. Phanuphak et al., Initiation of ART during early acute HIV infection preserves mucosal Th17 function and reverses HIV-related immune activation, PLoS Pathog, vol.10, issue.12, p.1004543, 2014.

S. Herout, M. Mandorfer, F. Breitenecker, T. Reiberger, K. Grabmeier-pfistershammer et al., Impact of early initiation of antiretroviral therapy in patients with acute HIV infection in, PLoS One, vol.11, issue.4, p.152910, 2016.

M. Buggert, J. Frederiksen, K. Noyan, J. Svard, B. Barqasho et al., Multiparametric bioinformatics distinguish the CD4/CD8 ratio as a suitable laboratory predictor of combined T cell pathogenesis in HIV infection, J Immunol, vol.192, issue.5, pp.2099-108, 2014.

J. Young, M. Psichogiou, L. Meyer, S. Ayayi, S. Grabar et al., CD4 cell count and the risk of AIDS or death in HIV-infected adults on combination antiretroviral therapy with a suppressed viral load: a longitudinal cohort study from COHERE, PLoS Med, vol.9, issue.3, p.1001194, 2012.

C. Mussini, P. Lorenzini, A. Cozzi-lepri, G. Lapadula, G. Marchetti et al., CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: an observational cohort study, Lancet HIV, vol.2, issue.3, pp.98-106, 2015.

W. Cao, V. Mehraj, B. Trottier, J. G. Baril, R. Leblanc et al., Early initiation rather than prolonged duration of antiretroviral therapy in HIV infection contributes to the normalization of CD8 T-cell counts, Clin Infect Dis, vol.62, issue.2, pp.250-57, 2016.

J. Thornhill, J. Inshaw, S. Oomeer, P. Kaleebu, D. Cooper et al., Enhanced normalisation of CD4/CD8 ratio with early antiretroviral therapy in primary HIV infection, J Int AIDS Soc, vol.17, p.19480, 2014.

L. Hocqueloux, V. Avettand-fenoel, S. Jacquot, T. Prazuck, E. Legac et al., Long-term antiretroviral therapy initiated during primary HIV-1 infection is key to achieving both low HIV reservoirs and normal T cell counts, J Antimicrob Chemother, vol.68, issue.5, pp.1169-78, 2013.

J. Ananworanich, C. P. Sacdalan, S. Pinyakorn, N. Chomont, D. Souza et al., Virological and immunological characteristics of HIVinfected individuals at the earliest stage of infection, J Virus Erad, vol.2, pp.43-48, 2016.

M. Hoenigl, A. Chaillon, and S. J. Little, CD4/CD8 cell ratio in acute HIV infection and the impact of early antiretroviral therapy, Clin Infect Dis, vol.63, pp.425-451, 2016.

A. Cheret, G. Nembot, A. Melard, C. Lascoux, L. Slama et al., Intensive five-drug antiretroviral therapy regimen versus standard triple-drug therapy during primary HIV-1 infection (OPTIPRIM-ANRS 147): a randomised, open-label, phase 3 trial, Lancet Infect Dis, vol.15, issue.4, pp.387-96, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01968121

M. Markowitz, T. H. Evering, D. Garmon, M. Caskey, L. Mar et al., A randomized open-label study of 3-versus 5-drug combination antiretroviral therapy in newly HIV-1-infected individuals, J Acquir Immune Defic Syndr, vol.66, issue.2, pp.140-187, 2014.

G. M. Bottani, M. L. Oreni, G. Orofino, P. Tau, D. N. Stuppino et al., Treatment outcome in HIV+ patients receiving 3-or 4-drug regimens during PHI, J Int AIDS Soc, vol.17, 2014.

J. Ananworanich, N. Chomont, J. L. Fletcher, S. Pinyakorn, A. Schuetz et al., Markers of HIV reservoir size and immune activation after treatment in acute HIV infection with and without raltegravir and maraviroc intensification, J Virus Erad, vol.1, issue.2, pp.116-138, 2015.

N. Phanuphak, N. Teeratakulpisarn, F. Van-griensven, N. Chomchey, S. Pinyakorn et al., Anogenital HIV RNA in Thai men who have sex with men in Bangkok during acute HIV infection and after randomization to standard vs. intensified antiretroviral regimens, J Int AIDS Soc, vol.18, p.19470, 2015.

H. J. Stellbrink, J. Reynes, A. Lazzarin, E. Voronin, F. Pulido et al., Dolutegravir in antiretroviral-naive adults with HIV-1: 96-week results from a randomized dose-ranging study, Aids, vol.27, issue.11, pp.1771-78, 2013.

J. M. Molina, B. Clotet, J. Van-lunzen, A. Lazzarin, M. Cavassini et al., Once-daily dolutegravir versus darunavir plus ritonavir for treatmentnaive adults with HIV-1 infection (FLAMINGO): 96 week results from a randomised, open-label, phase 3b study, Lancet HIV, vol.2, issue.4, pp.127-163, 2015.

P. Patel, J. D. Klausner, O. M. Bacon, S. Liska, M. Taylor et al., Detection of acute HIV infections in high-risk patients in California, J Acquir Immune Defic Syndr, vol.42, issue.1, pp.75-79, 2006.

P. Patel, D. Mackellar, P. Simmons, A. Uniyal, K. Gallagher et al., Detecting acute human immunodeficiency virus infection using 3 different screening immunoassays and nucleic acid amplification testing for human immunodeficiency virus RNA, Arch Intern Med, vol.170, issue.1, pp.66-74, 2006.

F. H. Priddy, C. D. Pilcher, R. H. Moore, P. Tambe, M. N. Park et al., Detection of acute HIV infections in an urban HIV counseling and testing population in the USA, J Acquir Immune Defic Syndr, vol.44, issue.2, pp.196-202, 2007.

J. Stekler, P. D. Swenson, R. W. Wood, H. H. Handsfield, and M. R. Golden, Targeted screening for primary HIV infection through pooled HIV-RNA testing in men who have sex with men, Aids, vol.19, issue.12, pp.1323-1348, 2005.

W. Stevens, E. Akkers, M. Myers, T. Motloung, C. D. Pilcher et al., High prevalence of undetected, acute HIV infection in a South Rutstein SE et al, Journal of the International AIDS Society, vol.20, 2017.

, Abstract presented at: Third IAS Conference on HIV Pathogenesis and Treatment, 2005.

T. Gaolathe, K. E. Wirth, M. P. Holme, J. Makhema, S. Moyo et al., Botswana's progress toward achieving the 2020 UNAIDS 90-90-90 antiretroviral therapy and virological suppression goals: a population-based survey, Lancet HIV, vol.3, issue.5, pp.221-251, 2016.

, UNAIDS. UNAIDS fact sheet, 2016.

G. H. Collaborators, H. Wang, T. M. Wolock, A. Carter, G. Nguyen et al., Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study, Lancet HIV, vol.3, issue.8, pp.361-87, 2015.

T. Liegler, M. Abdel-mohsen, L. G. Bentley, R. Atchison, T. Schmidt et al., HIV-1 drug resistance in the iPrEx preexposure prophylaxis trial, J Infect Dis, vol.210, issue.8, pp.1217-1244, 2014.

J. F. Weis, J. M. Baeten, C. O. Mccoy, C. Warth, D. Donnell et al., Preexposure prophylaxis-selected drug resistance decays rapidly after drug cessation, Aids, vol.30, issue.1, pp.31-35, 2016.

L. B. Brown, W. C. Miller, G. Kamanga, N. Nyirenda, P. Mmodzi et al., HIV partner notification is effective and feasible in sub-Saharan Africa: opportunities for HIV treatment and prevention, J Acquir Immune Defic Syndr, vol.56, issue.5, pp.437-479, 2011.

C. Henley, G. Forgwei, T. Welty, M. Golden, A. Adimora et al., Scale-up and case-finding effectiveness of an HIV partner services program in Cameroon: an innovative HIV prevention intervention for developing countries, Sex Transm Dis, vol.40, issue.12, pp.909-923, 2013.

R. Se, B. Lb, B. Ak, W. Sb, G. Kamanga et al., Cost-effectiveness of provider-based HIV partner notification in urban Malawi, Health Policy Plan, vol.29, issue.1, pp.115-141, 2014.

B. M. Wamuti, L. K. Erdman, P. Cherutich, M. Golden, M. Dunbar et al., Assisted partner notification services to augment HIV testing and linkage to care in Kenya: study protocol for a cluster randomized trial, Implement Sci, vol.10, p.23, 2015.

P. Cherutich, M. Golden, B. M. Wamuti, B. Richardson, K. H. Ásbjörnsdóttir et al., Effectiveness of partner services for HIV in Kenya: a cluster randomized trial. Abstract presented at: CROI, 2016.

N. E. Rosenberg, T. K. Mtande, F. Saidi, C. Stanley, J. E. Paile et al., Recruiting male partners for couple HIV testing and counselling in Malawi's option B+ programme: an unblinded randomised controlled trial, Lancet HIV, vol.2, issue.11, pp.483-91, 2015.

Z. S. Moore, S. Mccoy, J. Kuruc, M. Hilton, and P. Leone, Number of named partners and number of partners newly diagnosed with HIV infection identified by persons with acute versus established HIV infection, J Acquir Immune Defic Syndr, vol.52, issue.4, pp.509-522, 2009.

J. Davey, D. L. Beymer, M. R. Roberts, C. Bolan, R. K. Klausner et al., Sexual behavior during acute HIV infection among men who have sex with men, J Infect Dis, vol.213, issue.12, pp.2020-2041, 2016.

B. G. Brenner and M. A. Wainberg, Future of phylogeny in HIV prevention, J Acquir Immune Defic Syndr, vol.63, issue.2, pp.248-54, 2013.

A. B. Cope, K. A. Powers, J. D. Kuruc, P. A. Leone, J. A. Anderson et al., Ongoing HIV transmission and the HIV care continuum in North Carolina, Plos One, vol.10, issue.6, p.127950, 2015.

A. Corneli, A. Pettifor, G. Kamanga, C. Golin, K. Mckenna et al., HPTN 062: a feasibility and acceptability pilot intervention to reduce HIV transmission risk behaviors among individuals with acute and early HIV infection in Lilongwe, AIDS Behav, vol.18, issue.9, pp.1785-800, 2014.

A. Pettifor, A. Corneli, G. Kamanga, K. Mckenna, N. E. Rosenberg et al., HPTN 062: a pilot randomized controlled trial exploring the effect of a motivational-interviewing intervention on sexual behavior among individuals with acute HIV infection in Lilongwe, Plos One, vol.10, issue.5, p.124452, 2015.

A. J. Rodger, V. Cambiano, T. Bruun, P. Vernazza, S. Collins et al., Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy, Jama, vol.316, issue.2, pp.171-81, 2016.

S. Hino, C. Grodensky, G. Hamela, C. Massa, C. Golin et al., Influence of suspected source of infection on disclosure among people with acute HIV in Malawi, IAS, 2015.

C. Vancouver,

W. T. Steward, R. H. Remien, J. A. Higgins, R. Dubrow, S. D. Pinkerton et al., Behavior change following diagnosis with acute/early HIV infectiona move to serosorting with other HIV-infected individuals. The NIMH multisite acute HIV infection study: III, AIDS Behav, vol.13, issue.6, pp.1054-60, 2009.

J. H. Atkinson, J. A. Higgins, O. Vigil, R. Dubrow, R. H. Remien et al., Psychiatric context of acute/early HIV infection. The NIMH multisite acute HIV infection study: IV, AIDS Behav, vol.13, issue.6, pp.1061-67, 2009.

N. M. Zetola and C. D. Pilcher, Diagnosis and management of acute HIV infection, Infect Dis Clin North Am, vol.21, issue.1, pp.19-48, 2007.

J. A. Kelly, S. F. Morin, R. H. Remien, W. T. Steward, J. A. Higgins et al., Lessons learned about behavioral science and acute/early HIV infection. The NIMH MULTISITE ACUTE HIV infection study: V, AIDS Behav, vol.13, issue.6, pp.1068-74, 2009.

A. Pettifor, C. Macphail, A. Corneli, J. Sibeko, G. Kamanga et al., Continued high risk sexual behavior following diagnosis with acute HIV infection in South Africa and Malawi: implications for prevention, AIDS Behav, vol.15, issue.6, pp.1243-50, 2011.

A. B. Cope, A. M. Crooks, T. Chin, J. D. Kuruc, K. S. Mcgee et al., Incident sexually transmitted infection as a biomarker for high-risk sexual behavior after diagnosis of acute HIV, Sex Transm Dis, vol.41, issue.7, pp.447-52, 2014.

S. E. Rutstein, A. Pettifor, S. Phiri, D. Pasquale, A. M. Dennis et al., Abstract presented at: Pilot study of immediate antiretrovirals and behavioral intervention for persons with acute HIV infection: opportunity for interrupting transmission, 2015.

A. Brisbane,

C. D. Pilcher, C. Ospina-norvell, A. Dasgupta, D. Jones, W. Hartogensis et al., The effect of same-day observed initiation of antiretroviral therapy on HIV viral load and treatment outcomes in a U.S. public health setting, J Acquir Immune Defic Syndr, vol.74, issue.1, pp.44-51, 2017.

T. A. Crowell, N. Phanuphak, S. Pinyakorn, E. Kroon, J. L. Fletcher et al., Virologic failure is uncommon after treatment initiation during acute HIV infection, Aids, vol.30, pp.1943-50, 2016.

S. Kassutto, K. Maghsoudi, M. N. Johnston, G. K. Robbins, N. C. Burgett et al., Longitudinal analysis of clinical markers following antiretroviral therapy initiated during acute or early HIV type 1 infection, Clin Infect Dis, vol.42, issue.7, pp.1024-1055, 2006.

J. P. Routy, W. Cao, and V. Mehraj, Overcoming the challenge of diagnosis of early HIV infection: a stepping stone to optimal patient management, Expert Rev Anti Infect Ther, vol.13, issue.10, pp.1189-93, 2015.

P. M. Mugo, E. W. Wahome, E. N. Gichuru, G. M. Mwashigadi, A. N. Thiong'o et al., Effect of text message, phone call, and in-person appointment reminders on uptake of repeat HIV testing among outpatients screened for acute HIV infection in Kenya: a randomized controlled trial, PLoS One, vol.11, issue.4, p.153612, 2016.

M. S. Cohen, C. Dye, C. Fraser, W. C. Miller, K. A. Powers et al., HIV treatment as prevention: debate and commentary-will early infection compromise treatment-as-prevention strategies, PLoS Med, vol.9, issue.7, p.1001232, 2012.

M. L. Robb and J. Ananworanich, Lessons from acute HIV infection, Curr Opin HIV AIDS, vol.11, pp.555-60, 2016.

A. Saez-cirion, G. Pancino, L. O. Definition, and N. History, Heterogeneity of HIV controllers, Models of protection against HIV/SIV, pp.233-52, 2012.

J. F. Okulicz and O. Lambotte, Epidemiology and clinical characteristics of elite controllers, Curr Opin HIV AIDS, vol.6, issue.3, pp.163-68, 2011.

J. Karn, Estrogen blocks HIV re-emergence from latency and points to gender-specific differences in HIV reservoirs

B. C. Vancouver,

W. Stohr, S. Fidler, M. Mcclure, J. Weber, D. Cooper et al., Duration of HIV-1 viral suppression on cessation of antiretroviral therapy in primary infection correlates with time on therapy, PLoS One, vol.8, issue.10, p.78287, 2013.

E. Scully, M. Gandhi, R. Johnston, R. Gorelick, J. D. Lifson et al., Sex-based differences in HIV reservoir activity and residual immune activation. Abstract presented at: CROI, pp.13-16, 2017.

W. A. Seattle,

S. E. Rutstein, Journal of the International AIDS Society, vol.20, 2017.